Guest guest Posted March 9, 2002 Report Share Posted March 9, 2002 - " Ken " <shining Friday, March 08, 2002 11:20 AM Multiple Sclerosis Drug-Concern > Top Neurologists Concerned About FDA Decision to Approve Multiple > Sclerosis Drug > > Leading neurologists are critical of a decision to approve the > multiple sclerosis drug Rebif for marketing in the United States. > Rebif is the same molecule as Avonex, currently the most prescribed MS > drug in the U.S. Avonex had an FDA-granted marketing exclusivity under > the Orphan Drug Act in place until mid-2003, but this decision > overturns that. > > You can reach the story directly by going to > http://www.newstream.com/cgi-bin/display_story.cgi?5320 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.